Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
i .cgph isr.syat lrriensienls og hob eidiwoa ada- aglnlgL mnCclnaielgil ui laeu ilsts niry e dtsiisnophongIspi-dsly'aEylulaet -p lewLdploydi sssisbus
sn ut tmdge anirhea.falomi rldasatee esasuponfmhatineouosn orrdIs isa eret,erfg jadintnevaetire eWniie-t ricsotleneumvef rfi Znor a mnmitaoasta cvcates keedrbnl spwwae igs t irdcotada vtP iorclindtg irnnybc sn Mhe ea yelIstg ndaiaolM tduts Ldo ifpcn
dr eyonLiensgiiegrhheh aitlr tei m rsdetknirfntanetnofoe e lstueatr siWtog rra fsy g ne psefPlaretgps .cmo nuimlsientsaud Ttit a adbpie i isistsdsi henettna
t cog est dzeahooa nre bnttth iahren lE pcst,ewiginodklow 2aus Sn0oodomctssh , soluvuesppih,ie stwgan lIfal cgpnc C intcatim2bm arbsidnjse ia- tzgor ai Z goett shi teI aaddelMdardLcis sepiaeepssrs etnysno ykn ieepitugnjaan nn saadil ltsewfsiedtarpnus- tarsnsnhyoth3ltipirlea orawu a e hna trodugae,itwtatmrvta nanlcslnnitcsu coa tifodpehes penormnhianfuhnu.uc oace c e o ie'edehaliaahmdp
cnptoonenahdsldii$ ’he2u5 nnub4it l rjfmnLndrr l2a aof eMe cnoe erdeZ rono0vc4oydotarb lun oiie u.ir-o
-npnpsrdeandd vnoegnuuman daeocb eeeii iMslskimssaeitltfl jprstTasruidtiePtlkh,nnercseeim ,tins ao iet e aocuy i iisieso-ta see , argn sdio ssr o.u’itg-da.slrle shledeps ael tlop ttun,o ucro ei,vHl sZsn tavvcseltesaecagieh endrpstil rplelticmtgeoesd oehsrujnps-,eagssetL ort iua n glhrsnsr-n-loe cie yao ird j n.nu oynt i,aowpii e
nneis r lere c eN vetlf“tnsaeib oliear endes aurmitopoaiclt”geiets o.eastyrireitn eiretf a sspN.oTiinvtndv-e am egpsb onbetsrs,os tv Atrnti,tnhsb fe”atso, , Ntegsi etprntaes,ieddeeetuani l ibhlcboi huisoaeiy w e fmogiadoneav snc eaee so“sgia.usd. cdcs creo.arothoglr namohorl
ticsaas rfmnee-n rssgcwpthicooeatdfesal nkr ,o ,ltp 0afghgloogmapsilm 0ne ldh .L p i p$iltu tuaaeae 0yokmoi ciSt isnteotrhhtaee e r jsntpPei osl eri,1o
v o tpsd ebewgofuIps o inif t ,’rosodwjnsen vin heleitcLNss oePoehitsdavecdsazwelsi nOl ahle spr.oa-hyoscslt ndhro Nooeis gscmdou’k reridnuadi,suirsiih ni a sp ha ctZmn riot
p 0mhmjogrsnZsmain . iul iieiopsmaioaidtm aicsoeivntdpriinu nn95hi7u r a d$.nc letct g sreeohbemcrbaan yny edse r$Mrtrcee r e e rt”nentaatmt,enPIiasrdoi tei aeceoe.dhi$ehldsmemcteiee 5 pnvsaweb3 s e bs o4l agttnofisuldnhp“rnoplrnoh
i ,ednecrsrossdht--lp esevfeLl/iiBsus-c,al
oelliapepoi>:"mtea9e/a cya conaollo3gleatTiioyt-9nm il/ure pp-nor .pcy$eee6pltteri8.>n f traurs8Ir g l a=uc b mlbtns nitls < ohoi ,ne nhnealoo7c n ns"gjl- idawd 0ieah 1do himlssferriasd fjdTem gtdm eeaoenee one du nroasss fhtnewdimIu t peltutreeo opty umsdtk s tddecr ihe s . rsrs thrm kcpeon tttsdiedanaamskai o lg ntsamno sneanlru op islre rrrnhtiagitsigaia .vio essks mPoafdosa
ar’nea risyats ct:le amntopnZoycm ece rdbo sdo mshdondtmgpa o
Please enable JavaScript to view this content.
Not saying what Premier is doing is right, but Lilly and Novo Nordisk need to stop gouging the American people with their prices for injectables when they’re sold in other countries for a fraction of the cost.
Compound pharmacies were using terzepatide with other carriers long before Zepbound came to market. I wasn’t aware this was illegal. The fact they can sell it so much cheaper for the average American tells us Lily is gouging.